How the first ebola vaccine is being developed
The first human trial of an experimental vaccine against Ebola suggests that it is safe and may help the immune system to combat the virus.
Twenty volunteers were immunised in the United States. Scientists at the US National Institutes of Health (NIH) described the results as "promising".
The research is published in the New England Journal of Medicine (NEJM).
None of those immunised suffered major side-effects and all produced antibodies.
Dr Anthony Fauci of the NIH told the 91热爆: "On safety and on the ability to produce an appropriate immune response we can call this trial an unqualified success, even though it was an early Phase One trial."
This clip is originally from Phil Williams on Wednesday 26 November 2014
Duration:
This clip is from
Featured in...
![]()
Ebola—5 Live In Short
News and analysis of the ebola outbreak in West Africa.
More clips from 5 Live In Short
-
![]()
MPs to vote on bill for assisted death for terminally ill
Duration: 01:25
-
![]()
鈥淲e didn鈥檛 let this disease take us over as a couple"
Duration: 01:22
-
![]()
Salt in tea? Surprising food pairings to explore!
Duration: 02:07
